Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Sanofi India Limited ( (IN:SANOFI) ) has issued an update.
Sanofi India Limited announced the approval of its standalone and consolidated financial results for the quarter and year ending December 31, 2024. The company’s Board of Directors has also recommended a final dividend of ₹117 per equity share, pending shareholder approval at the upcoming Annual General Meeting. These developments highlight Sanofi India’s stable financial performance and commitment to shareholder returns, potentially strengthening its position in the pharmaceutical sector.
More about Sanofi India Limited
Sanofi India Limited operates in the pharmaceutical industry, focusing on the development and distribution of healthcare solutions. The company is known for its wide range of pharmaceutical products and services, catering to various health needs in the Indian market.
YTD Price Performance: -16.98%
Average Trading Volume: 1,117
Current Market Cap: 116.5B INR
For an in-depth examination of SANOFI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue